Sulphonylureas (e.g., gliclazide) and thiazolidinediones (e.g., pioglitazone) are older oral agents still used in certain situations, though they are less commonly prescribed due to side effect profiles, including weight gain and hypoglycaemia risk
as well as pharmaceutical and medical device intellectual property including trademark, copyright, trade secret and all aspects of patent law (due diligence, prosecution, opinion work, litigation, and transactional matters)
Similarly, after losing 80 pounds on a paleo diet, the weight all came back once I could no longer avoid the lure of grains and sugar
No evidence suggests that compounded semaglutide or tirzepatide from licensed 503A compounding pharmacies behaves differently from brand medications in terms of anticoagulant interaction
Current approaches to enhance CNS delivery of drugs across the brain barriers